Seelos TherapeuticsSEELQ
13F holders, Q3 2024 (September 30)15holders
$3.76avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Seelos Therapeutics Inc. (SEELQ) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($68K), Modera Wealth Management, LLC ($41K) and UBS Group AG ($32K).
- Company
- Seelos Therapeutics Inc.
- CUSIP
- 81577F406
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $8 |
| Exits | 0 | $0 |
Ownership 15 holders
| AdvisorShares Investments LLC | 0.01% | Add +231.3% | 18,113 | $68K |
| Modera Wealth Management, LLC | 0.00% | Add +732.0% | 10,805 | $41K |
| UBS Group AG | 0.00% | Add +278430.0% | 8,477 | $32K |
| Morgan Stanley | 0.00% | Reduce -50.2% | 675 | $3K |
| BlackRock, Inc. | 0.00% | — | 354 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -59.6% | 95 | $357 |
| Carmichael Hill & Associates, Inc. | 0.00% | Add +1.9% | 62 | $233 |
| Bank of America Corp. | 0.00% | Add +11.4% | 32 | $120 |
| JPMorgan Chase & Co. | 0.00% | Add +1.6% | 31 | $116 |
| Group One Trading LLC | 0.00% | Reduce -8.7% | 12 | $45 |
| Crewe Advisors LLC | 0.00% | No change | 7 | $27 |
| Vermillion & White Wealth Management Group, LLC | 0.00% | Reduce -6.5% | 7 | $26 |
| Wells Fargo & Company | 0.00% | Reduce -19.9% | 2 | $8 |
| Danske Bank A/S | 0.00% | New | 2 | $8 |
| NFSG Corp | 0.00% | Reduce -31.6% | 1 | $4 |
"% of holder's portfolio" is SEELQ's weight in each manager's 13F, not the share of Seelos Therapeutics Inc. the manager owns.